Individualization of dose and fractionation of radiotherapy for head and neck cancers

被引：0
作者：
Blanchard, P. [1 ,2 ,3 ]
Biau, J. [4 ,5 ,6 ]
Castelli, J. [7 ,8 ,9 ]
Tao, Y. [1 ]
Graff, P. [10 ]
Nguyen, F. [1 ]
机构：
[1] Gustave Roussy, Dept Radiotherapie Oncol, Canc Campus,114 Rue Edouard Vaillant, F-94800 Villejuif, France
[2] CESP, INSERM, U1018, F-94800 Villejuif, France
[3] Univ Paris Saclay, F-94800 Villejuif, France
[4] Ctr Jean Perrin, Dept Radiotherapie Oncol, F-63000 Clermont Ferrand, France
[5] Univ Clermont Auvergne, F-63000 Clermont Ferrand, France
[6] INSERM, Imagerie Mol & Strat Theranost U1240, F-63000 Clermont Ferrand, France
[7] Ctr Eugene Marquis, Dept Radiotherapie, F-35000 Rennes, France
[8] INSERM, LTSI U1099, F-35000 Rennes, France
[9] Univ Rennes 1, F-35000 Rennes, France
[10] IUCT Oncopole, Dept Radiotherapie, F-31000 Toulouse, France
来源：
CANCER RADIOTHERAPIE | 2019年 / 23卷 / 6-7期
关键词：
Head and neck cancer; Nasopharyngeal cancer; Chemotherapy; Epstein-Barr virus; Meta-analysis; Radiotherapy; Fractionation; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; TARGET VOLUMES CTV; HUMAN-PAPILLOMAVIRUS; RANDOMIZED-TRIAL; CONVENTIONAL RADIOTHERAPY; OROPHARYNGEAL CANCER; RADIATION-THERAPY; QUALITY-ASSURANCE; DE-ESCALATION;
D O I：
10.1016/j.canrad.2019.07.131
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Head and neck cancers comprise a variety of tumours depending on the sub-site, for which target volumes and the prescribed doses need to be individualized according to each patient's history and presentation. This article aims at describing the main factors involved in decision-making regarding dose and volume, as well as ongoing research. Contouring and treatment guidelines, use of altered fractionation, major prognostic factors, the role of Human papillomavirus and of functional imaging will be presented and discussed. (C) 2019 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：784 / 788
页数：5
相关论文
共 50 条
  • [31] Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers
    Azad, Abul Kalam
    Bairati, Isabelle
    Samson, Elodie
    Cheng, Dangxiao
    Cheng, Lu
    Mirshams, Maryam
    Savas, Sevtap
    Waldron, John
    Wang, Changshu
    Goldstein, David
    Xu, Wei
    Meyer, Francois
    Liu, Geoffrey
    CANCER, 2012, 118 (06) : 1554 - 1565
  • [32] Altered fractionation radiotherapy in head and neck squamous cell carcinoma
    Mallick, Supriya
    Benson, Rony
    Julka, Pramod K.
    Rath, Goura K.
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2016, 28 (02) : 73 - 80
  • [33] Role of Concomitant Chemoradiation in Locally Advanced Head and Neck Cancers
    Lasrado, Savita
    Moras, Kuldeep
    Pinto, George Jawahar Oliver
    Bhat, Mahesh
    Hegde, Sanath
    Sathian, Brijesh
    Luis, Neil Aaron
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (10) : 4147 - 4152
  • [34] IMRT - Biomarkers for dose escalation, dose de-escalation and personalized medicine in radiotherapy for head and neck cancer
    Andreassen, C. N.
    Eriksen, J. G.
    Jensen, K.
    Hansen, C. R.
    Sorensen, B. S.
    Lassen, P.
    Alsner, J.
    Schack, L. M. H.
    Overgaard, J.
    Grau, C.
    ORAL ONCOLOGY, 2018, 86 : 91 - 99
  • [35] A New Scoring-system for Estimating Overall Survival After Radiotherapy of Recurrent Head and Neck Cancers
    Rades, Dirk
    Seidl, Daniel
    Janssen, Stefan
    Hakim, Samer G.
    Wollenberg, Barbara
    Bartscht, Tobias
    Schild, Steven E.
    ANTICANCER RESEARCH, 2018, 38 (03) : 1611 - 1613
  • [36] Head and Neck Cancer: Changes in Artrokinematic Parameters of Neck and Swallowing Function after Radiotherapy
    Serel, Selen
    Demir, Numan
    Karaduman, A. Ayse
    Cengiz, Mustafa
    Yakut, Yavuz
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2013, 23 (02): : 97 - 103
  • [37] Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatin
    Peyraga, Guillaume
    Linot, Benjamin
    Yossi, Sena
    Gustin, Pierre
    Rousseau, Dominique
    Septans, Anne-Lise
    Breheret, Renaud
    Laccourreye, Laurent
    Rives, Pauline
    Capitain, Olivier
    ANTI-CANCER DRUGS, 2017, 28 (02) : 213 - 221
  • [38] Combining immunotherapy and radiotherapy in head and neck squamous cell cancers: which perspectives?
    Biau, Julian
    Bourhis, Jean
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (03) : 196 - 202
  • [39] The role of cetuximab in the management of head and neck cancers
    Kabolizadeh, Peyman
    Kubicek, Gregory J.
    Heron, Dwight E.
    Ferris, Robert L.
    Gibson, Michael K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (04) : 517 - 528
  • [40] An update on radiation therapy in head and neck cancers
    Mazzola, Rosario
    Fiorentino, Alba
    Ricchetti, Francesco
    Gregucci, Fabiana
    Corradini, Stefanie
    Alongi, Filippo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (04) : 359 - 364
12345